Navigation Links
Smith & Nephew releases new Modular Rail System in collaboration with Dr. Dror Paley
Date:3/20/2013

LONDON, March 20, 2013 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the introduction of a new Modular Rail System (MRS) for external fixation and deformity correction. This new treatment option highlights Smith & Nephew's increased investment in its extremities and limb restoration portfolio, and its commitment to advancing technology by working directly with surgeon inventors.  

(Photo: http://photos.prnewswire.com/prnh/20130320/CL80346)

Designed to correct bone deformities, malunions, non-unions and limb length discrepancies, the MRS takes advantage of the body's ability to grow new bone tissue. Using a segmented, external rail and a series of half-pins, the system holds various bone segments in correct alignment while new bone tissue grows and matures. Because the rail system is modular, it can be lengthened or shortened to meet the size needs of a patient, and can be joined with components from Smith & Nephew's TAYLOR SPATIAL FRAME™ and ILIZAROV™ circular fixation devices. And, unlike most rail systems, this new system is able to span a patient's joint, allowing it to bend and function normally while the device is in place. 

The surgeon expert behind the MRS concept is Dror Paley , MD, of the Paley Advanced Limb Lengthening Institute at St. Mary's Medical Center in West Palm Beach, Fla.

"Over the course of my 25-plus year career, I've tried many of the available rail systems on the market, none of which fully meet my needs," explains Dr. Paley. "Working with Smith & Nephew, I was able to design and develop a modular, multiplanar rail which can articulate across the hip, knee, ankle or elbow joints while allowing for lengthening and deformity correction."

"We're excited to introduce the Modular Rail System to our surgeon customers and their patients," says Mark Waugh , Divisional Vice President for Smith & Nephew's Extremities and Limb Restoration business. "The new system joins our industry-leading suite of limb restoration and deformity correction products, which includes the TAYLOR SPATIAL FRAME external fixator."

The Modular Rail System will be among the new technologies Smith & Nephew will highlight at this year's American Academy of Orthopedic Surgeons annual meeting.  Dr. Paley will present on the MRS at the Smith & Nephew booth (booth #1812) on Wednesday, March 20, at 2:30 pm.

About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith & Nephew has almost 10,500 employees and a presence in more than 90 countries. Annual sales in 2012 were more than $4.1 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).

For more information about Smith & Nephew, please visit:  www.smith-nephew.com

Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payors and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in integrating acquired businesses, and disruption that may result from changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business or competitive nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors.

Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

Trademark of Smith & Nephew.  Registered US Patent and Trademark Office.


'/>"/>
SOURCE Smith & Nephew
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
2. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
3. TNI BioTech Acquires Exclusive License To The Portfilio Of Patents Of Dr Ian S. Zagon, Dr. Patricia J. McLauglin And Dr. Jill Smith From The Penn State Research Foundation
4. David Smith Named Vice President of Operations for HealthTell
5. Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
6. Law Office of Brodsky & Smith, LLC Announces Investigation of Complete Genomics, Inc.
7. Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters
8. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
9. Serial Start-up Entrepreneur, Rudy Mazzocchi, once again Nominated for the Ernst & Young Entrepreneur of the Year Award.
10. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
11. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):